98 related articles for article (PubMed ID: 18550266)
1. Editorial comment on: Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma.
Mulders P
Eur Urol; 2009 Jul; 56(1):132-3. PubMed ID: 18550266
[No Abstract] [Full Text] [Related]
2. Editorial comment on: Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma.
Novara G
Eur Urol; 2009 Jul; 56(1):131-2. PubMed ID: 18550268
[No Abstract] [Full Text] [Related]
3. Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma.
Doehn C; Esser N; Pauels HG; Kiessig ST; Stelljes M; Grossmann A; Jocham D; Drevs J
Eur Urol; 2009 Jul; 56(1):123-31. PubMed ID: 18550267
[TBL] [Abstract][Full Text] [Related]
4. Future trends in research, prevention, and treatment of renal cell carcinoma.
Murphy GP
Semin Nephrol; 1987 Jun; 7(2):163-70. PubMed ID: 3306864
[No Abstract] [Full Text] [Related]
5. Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.
Sotomayor EM; Borrello I; Tubb E; Rattis FM; Bien H; Lu Z; Fein S; Schoenberger S; Levitsky HI
Nat Med; 1999 Jul; 5(7):780-7. PubMed ID: 10395323
[TBL] [Abstract][Full Text] [Related]
6. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
8. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
Nishitani MA; Sakai T; Ishii K; Zhang M; Nakano Y; Nitta Y; Miyazaki J; Kanayama HO; Kagawa S; Himeno K
Cancer Gene Ther; 2002 Feb; 9(2):156-63. PubMed ID: 11857033
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine: a 5-year follow-up analysis.
Repmann R; Goldschmidt AJ; Richter A
Anticancer Res; 2003; 23(2A):969-74. PubMed ID: 12820332
[TBL] [Abstract][Full Text] [Related]
11. A novel murine model of allogeneic vaccination against renal cancer.
Havranek EG; Labarthe MC; Ward S; Anderson CJ; Whelan MA; Pandha H
BJU Int; 2008 May; 101(9):1165-9. PubMed ID: 18399831
[TBL] [Abstract][Full Text] [Related]
12. [Tumor cell vaccination for treatment of renal cell carcinoma].
Kriegmair M; Oberneder R
Urologe A; 1995 May; 34(3):204-7. PubMed ID: 7610513
[TBL] [Abstract][Full Text] [Related]
13. [Relative value of adjuvant nephrectomy in metastatic renal cell carcinoma].
Slisów W; Marx G
Arch Geschwulstforsch; 1984; 54(6):483-90. PubMed ID: 6084496
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic approaches for renal cancer.
Pizza G; de Vinci C; Viza D
Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
[No Abstract] [Full Text] [Related]
15. The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma.
Prestwich RJ; Scott KJ; Brown J; Harnden P; Whelan P; Cartledge J; O'Donnell D; Pandha HS; Selby PJ; Banks RE; Merrick AE; Melcher AA
BJU Int; 2009 Mar; 103(6):740-6. PubMed ID: 19007376
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
Bellmunt J; Ribas A
Eur Urol; 2009 Jun; 55(6):1342-3. PubMed ID: 19201525
[No Abstract] [Full Text] [Related]
17. Surgery of metastatic renal cell carcinoma and use of renal infarction.
Swanson DA; Wallace S
Semin Surg Oncol; 1988; 4(2):124-8. PubMed ID: 3293153
[TBL] [Abstract][Full Text] [Related]
18. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
Clark PE
Eur Urol; 2009 Jun; 55(6):1343-4. PubMed ID: 19201523
[No Abstract] [Full Text] [Related]
19. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
Sakata Y; Ogura Y; Wakita T; Hayashi N; Sugimura Y
Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
[TBL] [Abstract][Full Text] [Related]
20. Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.
Barve M; Bender J; Senzer N; Cunningham C; Greco FA; McCune D; Steis R; Khong H; Richards D; Stephenson J; Ganesa P; Nemunaitis J; Ishioka G; Pappen B; Nemunaitis M; Morse M; Mills B; Maples PB; Sherman J; Nemunaitis JJ
J Clin Oncol; 2008 Sep; 26(27):4418-25. PubMed ID: 18802154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
